Skip to main content
. 2021 Nov 11;4(1):100387. doi: 10.1016/j.xkme.2021.09.004

Table 1.

Baseline Characteristics of CRIC Study Participants by Quartiles of Fasting DCA Level

Total N = 3,147 Quartile 1 n = 786 DCA 2.0-23.1 ng/mL Quartile 2 n = 787 DCA 23.2-68.4 ng/mL Quartile 3 n = 787 DCA 68.5-148.9 ng/mL Quartile 4 n = 787 DCA >148.9 ng/mL
Age, y 58 ± 11 59 ± 11 59 ± 11 60 ± 10
Female, N (%) 358 (45.6) 361 (45.9) 341 (43.3) 367 (46.6)
African American, N (%) 344 (43.8) 329 (41.8) 293 (37.2) 311 (39.5)
Hispanic, N (%) 81 (10.3) 92 (11.7) 97 (12.3) 91 (11.6)
Current smoking, N (%) 113 (14.4) 97 (12.3) 81 (10.3) 88 (11.2)
BMI, kg/m2 32.1 ± 8.0 31.9 ± 7.4 32.3 ± 7.9 32.4 ± 7.8
Systolic BP, mm Hg 126 ± 21 127 ± 23 126 ± 21 127 ± 21
Diabetes, N (%) 403 (51.3) 377 (47.9) 332 (42.2) 398 (50.6)
History of CVD, N (%) 290 (36.9) 268 (34.1) 268 (34.1) 273 (34.7)
Total cholesterol, mg/dL 180.6 ± 43.4 183.1 ± 45.2 182.3 ± 43.1 183.0 ± 43.7
Statin use, N (%) 506 (64.4) 466 (59.2) 440 (55.9) 432 (54.9)
No. of BP medications 2.6 ± 1.3 2.5 ± 1.3 2.4 ± 1.3 2.4 ± 1.3
eGFR, mL/min/1.73 m2 41.0 ± 16.2 42.1 ± 16.5 43.6 ± 15.7 43.3 ± 15.6
Urinary protein, g/24 h 0.20 (0.07-1.07) 0.18 (0.07-1.00) 0.16 (0.07-0.80) 0.15 (0.07-0.78)
Serum albumin, g/dL 4.02 ± 0.45 4.02 ± 0.45 4.08 ± 0.41 4.08 ± 0.42
Calcium, mg/dL 9.27 ± 0.53 9.29 ± 0.51 9.32 ± 0.51 9.31 ± 0.51
IL-6, pg/mL 1.80 (1.13-2.95) 1.74 (1.08-2.84) 1.82 (1.05-2.95) 1.93 (1.21-3.17)
CRP, mg/L 2.63 (1.08-6.87) 2.34 (1.03-6.00) 2.53 (0.94-5.74) 2.38 (1.02-5.99)
Phosphate, mg/dL 3.91 ± 1.24 3.85 ± 0.89 3.89 ± 1.17 3.83 ± 0.81
PTH, pg/mL 61.9 (39.6-105.0) 62.0 (40.0-101.0) 58.1 (40.0-92.4) 62.0 (39.0-93.7)
FGF23, RU/mL 164.0 (101.2-304.0) 147.3 (92.6-285.9) 132.1 (94.3-252.8) 143.1 (89.9-263.6)

Note: Continuous variables are presented as mean ± standard deviation for normally distributed data or as median and interquartile range for skewed data. Categorical variables are presented as total number and proportions.

Abbreviations: BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; CVD, cardiovascular disease; DCA, deoxycholic acid; eGFR, estimated glomerular filtration rate; FGF23, fibroblast growth factor 23; IL-6, interleukin 6; PTH, parathyroid hormone.